Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Lung Cancer

  Free Subscription


15.01.2018

1 Am J Ind Med
1 Ann Oncol
1 Arch Pathol Lab Med
1 Cancer
1 Clin Cancer Res
1 Clin Lung Cancer
1 Eur J Cancer
1 Eur J Cardiothorac Surg
2 Int J Cancer
2 J Cancer Res Clin Oncol
1 J Surg Oncol
1 J Thorac Cardiovasc Surg
1 J Thorac Oncol
1 N Engl J Med
1 Oncologist
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Ind Med

  1. PAVELA M, Uitti J, Pukkala E
    Cancer incidence among copper smelting and nickel refining workers in Finland.
    Am J Ind Med. 2017;60:87-95.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. KORDBACHEH T, Honeychurch J, Blackhall F, Faivre-Finn C, et al
    Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms.
    Ann Oncol. 2017 Dec 22. pii: 4772556. doi: 10.1093.
    PubMed     Text format     Abstract available


    Arch Pathol Lab Med

  3. HUSAIN AN, Colby TV, Ordonez NG, Allen TC, et al
    Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
    Arch Pathol Lab Med. 2018;142:89-108.
    PubMed     Text format     Abstract available


    Cancer

  4. CASSIDY RJ, Zhang X, Switchenko JM, Patel PR, et al
    Health care disparities among octogenarians and nonagenarians with stage III lung cancer.
    Cancer. 2018 Jan 8. doi: 10.1002/cncr.31077.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. THANGAVEL C, Boopathi E, Liu Y, McNair C, et al
    Therapeutic Challenge With a CDK 4/6 Inhibitor Induces an RB-dependent SMAC Mediated Apoptotic Response in Non-Small Cell Lung Cancer.
    Clin Cancer Res. 2018 Jan 8. pii: 1078-0432.CCR-17-2074.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  6. RECK M, Garon EB, Paz-Ares L, Ponce S, et al
    Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib Results.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30315.
    PubMed     Text format     Abstract available


    Eur J Cancer

  7. SHI Y, Lin P, Ho EY, Nock CJ, et al
    Nivolumab-associated nausea and vomiting as an immune adverse event.
    Eur J Cancer. 2017;84:367-369.
    PubMed     Text format    


    Eur J Cardiothorac Surg

  8. WEDER W, Moghanaki D, Stiles B, Siva S, et al
    The great debate flashes: Surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer.
    Eur J Cardiothorac Surg. 2017 Dec 21. pii: 4772266. doi: 10.1093.
    PubMed     Text format     Abstract available


    Int J Cancer

  9. MORRIS S, Vachani A, Pass HI, Rom WN, et al
    Whole Blood FPR1 mRNA Expression Predicts Both Non-Small Cell and Small Cell Lung Cancer.
    Int J Cancer. 2018 Jan 5. doi: 10.1002/ijc.31245.
    PubMed     Text format     Abstract available

  10. XU X, Huang Z, Zheng L, Fan Y, et al
    The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancer.
    Int J Cancer. 2018 Jan 10. doi: 10.1002/ijc.31252.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  11. ZHANG Y, Ma Y, Li Y, Shen X, et al
    Are exon 19 deletions and L858R different in early stage lung adenocarcinoma?
    J Cancer Res Clin Oncol. 2018;144:165-171.
    PubMed     Text format     Abstract available

  12. MATSUO Y, Shiomi K, Sonoda D, Mikubo M, et al
    Molecular alterations in a new cell line (KU-Lu-MPPt3) established from a human lung adenocarcinoma with a micropapillary pattern.
    J Cancer Res Clin Oncol. 2018;144:75-87.
    PubMed     Text format     Abstract available


    J Surg Oncol

  13. SMITHY JW, Rosen JE, Gao SJ, Kim AW, et al
    Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease.
    J Surg Oncol. 2017;116:1193-1196.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  14. BRUNELLI A
    Time of modeling survival of patients with stage III-N2 non-small cell lung cancer: Before or after surgery makes a difference.
    J Thorac Cardiovasc Surg. 2017 Dec 12. pii: S0022-5223(17)32837.
    PubMed     Text format    


    J Thorac Oncol

  15. HOTTA K, Aoe K, Kozuki T, Ohashi K, et al
    A Phase II Study of Trastuzumab Emtansine in HER2-positive Non-Small-Cell Lung Cancer.
    J Thorac Oncol. 2017 Dec 4. pii: S1556-0864(17)33065.
    PubMed     Text format     Abstract available


    N Engl J Med

  16. POPAT S
    Osimertinib as First-Line Treatment in EGFR-Mutated Non-Small-Cell Lung Cancer.
    N Engl J Med. 2018;378:192-193.
    PubMed     Text format    


    Oncologist

  17. KHOZIN S, Abernethy AP, Nussbaum NC, Zhi J, et al
    Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval.
    Oncologist. 2018 Jan 9. pii: theoncologist.2017-0353.
    PubMed     Text format     Abstract available


    PLoS One

  18. TAKAHASHI Y, Yasui T, Tamari K, Minami K, et al
    Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma.
    PLoS One. 2017;12:e0189697.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  19. GONCALVES MD, Hwang SK, Pauli C, Murphy CJ, et al
    Fenofibrate prevents skeletal muscle loss in mice with lung cancer.
    Proc Natl Acad Sci U S A. 2018 Jan 8. pii: 1714703115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: